Wyeth launches new Prempro ads

Share this article:

Healthworld Communications, New York, has created a new ad campaign for Wyeth's Prempro that includes a 60-second television spot and a consumer print ad. The ads begin running this month. The 60-second spot will air on network programs such as Entertainment Tonight and CSI: Miami.

The campaign is designed to educate women about the appropriate use of hormone therapy and seeks to encourage dialogue between women and their healthcare professionals about the treatment of menopausal symptoms.

"The new consumer advertising campaign gives clear and balanced information about the clinically proven symptom relief and bone protection that Prempro can provide to women who experience moderate to severe menopausal symptoms," says Joseph Mahady, president of Wyeth Pharmaceuticals, North America and Global Businesses. "Prempro will be right for some women and not for others. This campaign will encourage a woman to talk with her healthcare professional about menopausal symptoms and whether hormone therapy is right for her."

Share this article:
You must be a registered member of MMM to post a comment.
close

Next Article in Channel

Email Newsletters

MM&M EBOOK: PATIENT ACCESS

Patient access to pharmaceuticals is a tale of two worlds—affordability has improved for the majority, while the minority is hampered by cost, distribution and red tape. To provide marketers with a well-rounded perspective, MM&M presents this e-book chock full of key insights. Click here to access it.

More in Channel

Five things for pharma marketers to know: Monday, September 15

Five things for pharma marketers to know: ...

Pharma has sought 76 meetings with FDA over biosimilars; Gilead licenses Sovaldi to India generic drugmakers; Pfizer and Ranbaxy Lipitor lawsuit dismissed.

Liraglutide, aiming for new indication, gets new name

Liraglutide, aiming for new indication, gets new name

Why Novo Nordisk is choosing not to leverage Victoza's brand equity as it seeks a weight-loss indication for liraglutide.

Five things for pharma marketers to know: Friday, September 12

Five things for pharma marketers to know: Friday, ...

An FDA panel voted in favor of liraglutide for weight loss; Allergan investors backing an attempted takeover of the firm crossed a critical threshold; and 100 million health wearables are ...